Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Health care industry Companies Business News
From CNBC.com News
World's largest luxury group LVMH posts better than feared full-year sales
Tags Business LVMH Moet Hennessy Louis Vuitton SE Earnings
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags LILLY DRN Medicare Health & Science
From CNBC.com News
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
Tags Novo Nordisk A/S Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Healthy Returns Johnson & Johnson Health care industry
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags Banks World economy Politics
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Waystar Holding Corp IQVIA Holdings Inc Health care industry
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Business Biotechnology Novo Nordisk A/S
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Health care industry Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags Business News Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
Tags Markets PepsiCo Inc/ Investment strategy
From CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Tags Dexcom Inc Technology Waystar Holding Corp
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Companies Weight management Health care policy
From CNBC.com News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
Tags Daily Open Novo Nordisk A/S Asia Markets
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Health & Science Companies Business
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Biotechnology Breaking News: Europe Breaking News: Markets
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags AstraZeneca PLC Health care industry Pfizer Inc
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags Economy Novo Nordisk A/S Dassault Systemes SE
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Healthy Returns Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Health & Science Social issues LILLY DRN
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Biotechnology Business Health & Science
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Technology Health care industry Prescription drugs
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Bristol/Myers Squibb Co
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Biotech and Pharmaceuticals Pharmaceuticals Goodrx Holdings Inc
From CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
Tags Breaking News: Investing Investment strategy Markets
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Business News Health care industry Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Business Earnings Best Buy Co Inc
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Business Biotechnology Health & Science
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Pharmaceuticals Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.